(Q42484803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

ChEBI release 2020-05-28

Euphorbia peplus

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Steven M Ogbourne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

J R Ramsay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A Suhrbier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

J H Aylward

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

S-J Cozzi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

M G Poulsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

K C Baumann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

P Welburn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

G L Redlich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

English

0 references

publication date

27 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

633-636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

The spectrum of ocular inflammation caused by euphorbia plant sap.

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

A systematic review of treatment modalities for primary basal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

Proceedings of the First International Conference on PEP005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10184.X

10.1111/J.1365-2133.2010.10184.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375515%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference